Indian Pharmacological Society

Indian Pharmacology

The Indian Pharmacological Society (IPS) has been a leading institution in the field of pharmacology since its inception in 1951. With its dedication to promoting research, education, and practice of pharmacology in India, the IPS has made significant contributions to the development and growth of the pharmaceutical industry in the country. In this article, we will explore the history, objectives, and activities of the IPS and delve into the significance of homeopathic pharmacy within the broader context of pharmacological practice in India.

History of the Indian Pharmacological Society

The Indian Pharmacological Society was established in December 1951 by a group of visionary pharmacologists, including Dr. B. N. Ghosh, Dr. K. P. Bhargava, and Dr. Nitya Nand. These pioneering scientists aimed to create a platform for Indian pharmacologists to collaborate, share research findings, and contribute to the development of the pharmaceutical sector in India.

The first annual conference of the IPS took place in 1952 in Calcutta (now Kolkata), marking the beginning of a rich legacy of annual scientific meetings that have since grown in size, scope, and impact. The society now boasts a membership of over 3,000 professionals, including scientists, educators, and clinicians from various fields of pharmacology.

Objectives and Activities of the IPS

The primary objectives of the Indian Pharmacological Society are:

a. To advance the knowledge and practice of pharmacology in India
b. To promote research, education, and training in pharmacology and related disciplines
c. To encourage interaction and collaboration among pharmacologists and other scientific professionals
d. To represent the interests of Indian pharmacologists on national and international platforms

To achieve these objectives, the IPS undertakes a wide range of activities, such as:

a. Annual conferences: The society organizes annual conferences, offering a forum for pharmacologists to present their research findings, exchange ideas, and forge collaborations. These conferences include keynote lectures, symposia, workshops, and poster presentations, providing a comprehensive overview of the latest advancements in pharmacology.

b. Publication of the Indian Journal of Pharmacology (IJP): The IJP is the official publication of the IPS, which publishes original research articles, reviews, case reports, and letters to the editor in various areas of pharmacology. The journal is indexed in multiple databases and adheres to strict standards of peer review and ethical guidelines.

c. Training programs and workshops: The IPS regularly organizes workshops, seminars, and training programs to enhance the knowledge and skills of pharmacologists, with a focus on emerging trends and technologies in the field.

d. Awards and recognitions: The society confers various awards and honors to recognize the contributions of its members and encourage excellence in pharmacological research and practice.

The Role of Homeopathic Pharmacy in Indian Pharmacology

Homeopathic pharmacy is a distinct discipline within the broader scope of pharmacology, dealing with the preparation, dispensing, and usage of homeopathic remedies. Homeopathy, a holistic system of medicine founded by German physician Samuel Hahnemann in the late 18th century, is based on the principle of “like cures like.” Homeopathic remedies are highly diluted substances derived from natural sources, which are believed to stimulate the body’s innate healing abilities.

In India, homeopathy enjoys widespread acceptance and popularity, with an extensive network of practitioners, pharmacies, and educational institutions. Homeopathic pharmacy plays a vital role in the overall landscape of Indian pharmacology, offering an alternative and complementary approach to conventional drug therapy.

The Indian Pharmacological Society, recognizing the importance of homeopathy, encourages the collaboration between homeopathic and allopathic pharmacologists. The society promotes research and education in homeopathicpharmacy, facilitating the integration of homeopathy into mainstream pharmacological practice. Some noteworthy endeavors include:

a. Inclusion of homeopathic pharmacy topics in IPS conferences: Homeopathic pharmacy is often featured as a part of the scientific programs at IPS annual conferences, with presentations and workshops highlighting the latest research findings, clinical experiences, and advances in homeopathic preparations.

b. Collaboration with homeopathic institutions: The IPS fosters collaboration with homeopathic colleges, research centers, and professional associations to advance the field of homeopathic pharmacy and promote evidence-based practice.

c. Encouraging interdisciplinary research: The society actively promotes interdisciplinary research involving homeopathy, pharmacology, and other allied disciplines to enhance the scientific understanding of homeopathic principles and therapeutic applications.

d. Advocacy for regulatory standards and quality control: The IPS supports the development and implementation of regulatory standards and quality control measures for homeopathic medicines, ensuring their safety, efficacy, and consistency.

Challenges and Opportunities for Homeopathic Pharmacy in India

Despite its popularity and widespread usage, homeopathic pharmacy in India faces several challenges, including:

a. Limited research funding: Compared to conventional pharmacology, homeopathic research receives significantly less funding, which can hinder the progress and development of the discipline.

b. Skepticism and lack of acceptance: Homeopathy often faces skepticism and resistance from the mainstream scientific community due to the lack of robust evidence supporting its efficacy and the controversial nature of its fundamental principles.

c. Inadequate regulatory and quality control measures: The absence of stringent regulatory and quality control measures for homeopathic medicines raises concerns about the safety and efficacy of these products.

However, these challenges also present opportunities for growth and development in the field of homeopathic pharmacy:

a. Strengthening research infrastructure: Investing in research infrastructure and funding opportunities can facilitate the generation of high-quality scientific evidence to support homeopathic principles and practice.

b. Promoting evidence-based practice: Encouraging homeopathic practitioners to adopt evidence-based practices can help build credibility and trust in the efficacy of homeopathic remedies among the scientific community and the general public.

c. Enhancing collaboration and integration: Fostering collaboration between homeopathic and allopathic pharmacologists can promote the integration of homeopathy into mainstream healthcare, offering patients a more comprehensive and holistic approach to treatment.

The Indian Pharmacological Society (IPS) is a professional organization that aims to promote the advancement of pharmacology in India. As such, it is common for the IPS to engage with various stakeholders in the field, including pharmaceutical companies. These interactions may take various forms, such as:

Collaborations and partnerships: The IPS may collaborate with pharmaceutical companies to promote research, development, and innovation in pharmacology. Such partnerships can involve joint research projects, funding support, or sharing of resources and expertise.

Sponsorships: Pharmaceutical companies may sponsor events, conferences, or workshops organized by the IPS, providing financial support and resources to facilitate these gatherings. This collaboration enables the IPS to organize high-quality educational and networking events for its members while giving the sponsoring companies an opportunity to showcase their products and services to a targeted audience of pharmacology professionals.

Educational initiatives: Pharmaceutical companies may collaborate with the IPS to develop educational materials, training programs, or courses to enhance the knowledge and skills of pharmacology professionals. These initiatives can help ensure that practitioners are up-to-date with the latest developments in the field and are well-equipped to provide the best possible care to their patients.

Policy advocacy: The IPS may engage with pharmaceutical companies to advocate for policy changes that promote the interests of the pharmacology community, such as improving regulatory standards, enhancing research infrastructure, and fostering a favorable environment for the growth and development of the pharmaceutical industry in India.

It is important to note that while the IPS may interact and collaborate with pharmaceutical companies, it must maintain its independence and ensure that its activities and decisions are guided by the best interests of its members and the wider pharmacology community. This involves transparent communication, clear ethical guidelines, and a commitment to evidence-based practice and scientific integrity.

Forging Partnerships for Progress: The Indian Pharmacological Society’s Collaborative Endeavors with Leading Pharmaceutical Companies

Sun Pharmaceutical Industries Ltd. – India’s largest pharmaceutical company, specializing in generic drugs, branded formulations, and active pharmaceutical ingredients (APIs).

Lupin Limited – A leading Indian multinational pharmaceutical company that focuses on branded and generic formulations, biotechnology products, and APIs.

Dr. Reddy’s Laboratories – A multinational pharmaceutical company with a strong presence in India, offering a wide range of products, including generic drugs, over-the-counter medications, and APIs.

Cipla Limited – A global pharmaceutical company that provides a variety of prescription and over-the-counter medications, focusing on respiratory, oncology, and antiretroviral therapies.

Cadila Healthcare Limited (Zydus Cadila) – A leading Indian pharmaceutical company with a diversified product portfolio, including branded and generic formulations, biologics, and APIs.

Aurobindo Pharma Limited – A prominent Indian pharmaceutical company that manufactures generic pharmaceuticals and APIs.

These are just a few examples, and there may be many other smaller or region-specific pharmaceutical companies that have interacted with the IPS over the years. It is essential to understand that collaborations between the IPS and pharmaceutical companies are not uncommon, as both entities share the goal of advancing pharmacological knowledge and improving patient care. However, it is crucial for the IPS to maintain transparency, ethical standards, and scientific integrity in all its interactions and partnerships.


The Indian Pharmacological Society has played a pivotal role in shaping the landscape of pharmacology in India, including the advancement and recognition of homeopathic pharmacy. By embracing the principles of homeopathy and fostering collaboration between diverse disciplines, the IPS has helped create an environment that nurtures innovation, growth, and excellence in the field of pharmacology. As the society continues to support the development of homeopathic pharmacy, it is poised to contribute significantly to the improvement of healthcare and the well-being of the Indian population.